In the preceding three months, 4 analysts have released ratings for CareDx (CDNA) , presenting a wide array of perspectives from bullish to bearish.

Underdog and Crypto.com launch the first prediction market exchange on a major sports app, offering real-time trading in 16 ...

BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ -- RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT cDNA Synthesis and ...

Investing.com - Caredx Inc (NASDAQ: CDNA) reported second quarter EPS of $0.10, $0.20 better than the analyst estimate of ...

CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

Investors in CareDx Inc (Symbol: CDNA) saw new options begin trading this week, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ...

Statistica Sinica, Vol. 12, No. 1, A Special Issue on Bioinformatics (January 2002), pp. 111-139 (29 pages) DNA microarrays are a new and promising biotechnology which allows the monitoring of ...

Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S. equities rose ...

Fintel reports that on January 15, 2025, Wells Fargo upgraded their outlook for CareDx (NasdaqGM:CDNA) from Underweight to Equal-Weight. Analyst Price Forecast Suggests 55.96% Upside As of December 24 ...